期刊文献+

多靶点治疗狼疮性肾炎的临床分析 被引量:1

Clinical anglysis of multi-target treatment of lupus nephritis
下载PDF
导出
摘要 目的:探讨多靶点治疗狼疮性肾炎的临床疗效。方法:回顾性分析本院收治的狼疮性肾炎患者46例的临床资料,依据肾炎治疗方式分为普通观察组(23例)和多靶点对照组(23例)。普通观察组在整个治疗过程中给予环磷酰胺加入0.9%氯化钠注射液中静滴或静注。而多靶点对照组采用多靶点+强的松药物,并在治疗中加用环磷酰胺(CTX)。结果:多靶点对照组治疗效果优于普通观察组,多靶点对照组总治愈率为91.3%,普通观察组治愈率为34.78%。结论:在整个治疗过程中运用多靶点+强的松的稳固治疗,为狼疮性肾炎患者减轻了疾病上的疼痛,治愈率高,安全性大。所以,多靶点治疗在临床上是有效、可观的治疗方法,是值得临床推广的一种治疗方法。 Objective:To investigate the clinical effect of the multi-target treatment of lupus nephritis.Methods:Retrospective analysis of patients with lupus nephritis were treated 46 cases of clinical data,based on general observation of nephritis were divided into treatment group (23 cases) patients,and multi-target control group (23 cases) patients.General observation group in the whole course of treatment for cyclophosphamide 0.9% sodium chloride injection or intravenous infusion. The multi-target control group,multi-target and prednisone drug, the treatment was added in CTX.Results:The multi-target control group was superior to the observation group,multi-target control group cure rate was 91.3% ,general observation group the cure rate was 34.78%.Conclusion:The use of the entire course of treatment,the stability of multi-target and prednisone therapy for patients with lupus nephritis to reduce the pain of disease,high cure rate,safety,great.Therefore,the multitarget therapy is clinically effective and substantial treatment is worth promoting as a medical treatment.
作者 李建平
出处 《中国当代医药》 2010年第20期31-32,共2页 China Modern Medicine
关键词 多靶点 狼疮性肾炎 安全性大 Multi-target Lupus nephritis Safety of large
  • 相关文献

参考文献7

二级参考文献39

  • 1宋彬,徐隽,罗小华,吴苾,程燕,张瑾.螺旋CT检查在诊断狼疮性缺血性肠病中的价值[J].中国普外基础与临床杂志,2004,11(4):359-363. 被引量:13
  • 2唐国凤,梁科,吴丽萌,邹桂华,汪小娟.白细胞介素-18治疗狼疮性肾炎36例临床体会[J].实用临床医药杂志,2006,10(4):102-102. 被引量:6
  • 3Bombardier C, Gladman DD, Urowitz M B, et al. Derivation of the SLEDAI. A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE[J]. Arthritis Rheum, 1992,35 ( 6 ) : 630.
  • 4Imbach P,Barandun S,d'Apuzzo V,et al. High-dose intravenous gammaglobulin for idiopathic thromboeytopeni purpura in childhood[J]. Lancet, 1981,1 (8232): 1228.
  • 5Palla R,Cirami C,Panichi V,et al. lntraveaous immunoglobulia therapy of membraaou nephropathy: efficacy and safety[J]. Clia Nephrol, 1991,35 (1):98.
  • 6Pallach S, Cunningham-Rundles N, Smithwick EM, et al. Highdose intravenous gammaglobulin for auto-immune neutropenia[J].N Engl J Med, 1982,307(4):253.
  • 7Ballow M. Mechanisms of action of intravenous immune serum gtobuhn inautoimmune and inflammatory diseases[J]. J Allergy Clin Immunol, 1997, 100(2) : 151-157.
  • 8Brand A, Vuist WM,Vansehaik IM. In vitro investigation of immunoglobulin treatment mechanismin autoimmune diseases[J]. Clin Exp Rheumatol, 1996,14(Suppll 5) :27-30.
  • 9Grande JP,Balow JE. Renal biopsy in lupus nephritis. Lupus,1998,7:611-617.
  • 10Struz F,Muller GA.The progression of chronic renal disease.Nephron,1995,69:371-379.

共引文献160

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部